ResearchMoz

China Diagnostic Reagent Industry Report, 2012-2014

Research In China
Published Date » 2013-01-04
No. Of Pages » 86

Chinas diagnostic reagent industry has formed a certain market scale and basis, and is marching from the introduction stage to the growth stage. With the continuous growth in Chinas medical care investment and per capita health care spending, the Chinas diagnostic reagent market has a promising prospect. 

In vitro diagnostic reagents account for more than 90.0% of the output of Chinas diagnostic reagent industry. In 2011, the market scale of in vitro diagnostic reagents reached about RMB 11.4 billion in China, the industry will maintain a growth rate of 15%-20% in the future, and the market scale will hit RMB 20.8 billion in 2015. 

At present, there are only a few integrated in vitro diagnostic reagent enterprises with strong strength in Chinas diagnostic reagent market, including KHB and Fosun Pharma; other enterprises such as Da An Gene, BioSino, Leadman and Livzon have competitive advantages in specific fields such as biochemical diagnosis, immunodiagnosis, and molecular diagnosis. Meanwhile, Chinas in vitro diagnostic reagent industry concentration is low. Among 300-400 enterprises, there are only about 20 enterprises with annual sales of more than RMB 100 million. The enterprises are generally small and have a few product varieties. In 2011, KHB, Da An Gene, BioSino, Leadman only occupied 3.8%, 2.3%, 1.9%, 1.6% of the market respectively. 

As a high-tech industry, the profitability of the overall Chinese diagnostic reagent industry is high. In 2011, among major Chinese diagnostic reagent enterprises, KHB, Da An Gene, BioSino, Kinghawk, Livzon, Leadman all achieved a gross margin of more than 50%; Fosun Pharma reached a gross margin of 40.4%, since diagnostic reagent and instrument business accounts for a lower proportion of its revenue. With the improvement of industry concentration, its expected that the advantageous enterprises with strong capability of technological innovation and large production scale will obtain higher market share and profitability. 

China Diagnostic Reagent Industry Report, 2012-2014 mainly includes the following contents:

  • Market scale, market structure, import and export, competitive landscape, profitability, entry barriers of Chinas diagnostic reagent industry;
  • Regulatory system and policy, industry policy, industrial chain, upstream and downstream of Chinas diagnostic reagent industry; 
  • Development forecast of Chinas diagnostic reagent industry, including the forecast of market scale, major market segments, industry competition, and enterprise development trends;
  • Production, operation, investment, M&A, diagnostic reagent business and development prospect of 15 Chinese diagnostic reagent enterprises.
Table of Content

1. Overview of Diagnostic Reagent Industry
1.1 Definition
1.2 Classification

2. China Diagnostic Reagent Industry

2.1 Overview
2.2 Market Structure
2.3 Import and Export
2.3.1 Import
2.3.2 Export
2.4 Competitive Landscape
2.4.1 Biochemical Diagnostic Reagents
2.4.2 Immune Diagnostic Reagents
2.4.3 Molecular Diagnostic Reagents
2.4.4 Integrated In Vitro Diagnostic Reagents
2.5 Profitability
2.6 Entry Barriers
2.6.1 Technical Barriers
2.6.2 Quality and Brand Barriers
2.6.3 Marketing Channel Barriers
2.6.4 Market Access Barriers

3. Development Environment of China Diagnostic Reagent Industry
3.1 Policy Environment
3.1.1 Regulatory Policy
3.1.2 Industry Policy
3.2 Upstream and Downstream Industries
3.2.1 Industrial Chain
3.2.2 Upstream
3.2.3 Downstream

4. Development Forecast of China Diagnostic Reagent Industry
4.1 Overall Forecast
4.1.1 Market Demand Drivers
4.1.2 Market Scale Forecast
4.2 Development Trends of Diagnostic Reagent Industry
4.2.1 Biochemical Diagnosis and Immunodiagnosis Will Still Be the Mainstream
4.2.2 Industry Concentration Will Increase
4.2.3 Enterprises with Complete Product Line Integrating Reagents and Instruments will Win

5. Major Chinese Diagnostic Reagent Enterprises

5.1 Shanghai Kehua Bio-engineering Co., Ltd. (KHB)
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 R & D and Investment
5.1.6 Customers
5.1.7 Diagnostic Reagent Business
5.1.8 Forecast and Prospect
5.2 Da An Gene Co., Ltd.
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R & D and Investment
5.2.6 Diagnostic Reagent Business
5.2.7 Forecast and Prospect
5.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 R & D and Investment
5.3.6 Diagnostic Reagent Business
5.3.7 Forecast and Prospect
5.4 BioSino Bio-technology and Science Inc.
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 R & D and Investment
5.4.5 Forecast and Prospect
5.5 Beijing Kinghawk Pharmaceutical Co., Ltd.
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 Diagnostic Reagent Business
5.5.6 Forecast and Prospect
5.6 Livzon Pharmaceutical Group Inc.
5.6.1 Profile
5.6.2 Operation
5.6.3 Revenue Structure
5.6.4 Gross Margin
5.6.5 Diagnostic Reagent Business
5.6.6 Forecast and Prospect
5.7 Beijing Leadman Biochemistry Co., Ltd.
5.7.1 Profile
5.7.2 Operation
5.7.3 Revenue Structure
5.7.4 Gross Margin
5.7.5 R & D and Investment
5.7.6 Customers
5.7.7 Diagnostic Reagent Business
5.7.8 Forecast and Prospect
5.8 Acon Biotech (Hangzhou) Co., Ltd.
5.8.1 Profile
5.8.2 Operation
5.8.3 Development
5.9 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
5.9.1 Profile
5.9.2 Operation
5.9.3 Development
5.10 Shanghai Rongsheng Biotech Co., Ltd. (Rsbio)
5.10.1 Profile
5.10.2 Operation
5.10.3 Development
5.11 Shenzhen PG Biotech Co., Ltd.
5.11.1 Profile
5.11.2 Operation
5.12 Shanghai Upper Bio-Tech Pharma Co., Ltd.
5.12.1 Profile
5.12.2 Operation
5.12.3 Development
5.13 Inverness Medical (Shanghai) Co., Ltd.
5.13.1 Profile
5.13.2 Operation
5.14 Blue Cross Bio-Medical (Beijing) Co., Ltd.
5.14.1 Profile
5.14.2 Operation
5.14.3 Development
5.15 Beijing North Institute of Biological Technology (BNIBT)
5.15.1 Profile
5.15.2 Operation
5.15.3 Development

List of Tables

NA

List of Figures

NA

Upcoming Reports:

Hydrogen Peroxide Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Hydrogen Peroxide is the simplest and versatile peroxide formed due to a chemical reaction between hydrogen and oxygen. It is a liquid, which is more viscous than water and is colorless in the diluted form. It is generally used as a chemical disinfectant. In addition, hydrogen peroxide is a strong oxidizing agent. It is naturally produced in human body which helps increasing immunity. It is used in a variety of medical and personal applications such as bleaching, sterilization, sanitizer, toothpastes, mouthwashes and hair color among others. In order to increase the crop...
Oral Hygiene Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts, 2012 - 2018
By - Transparency Market Research
An increase in ageing population and rising demand for oral care are offering enormous opportunities for product innovations and developments to oral care providers. Rising awareness of oral care and the quality of services provided by dental care providers are some important factors driving the oral hygiene market. In addition to this, innovative products development and rising demand for aesthetic dentistry in developing nations is expected to drive the growth of the oral hygiene industry.  Emerging technologies will have a great impact on the overall growth of this...
Chronic Myeloid Leukemia Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Chronic Myeloid Leukemia (CML) is a type of blood cancer caused by uncontrolled growth of the cells in bone marrow. CML is a type of myeloproliferative disease which is characterized by the chromosomal translocation. Patients suffering from CML show increased susceptibility to infections, thrombocytopenia, anemia and may also have enlarged spleen which causes pain on the left side. Incidence rate of CML is high in men and is the second most common type of cancer occurring in male adults. Women who are above 50 years in age are expected to suffer from this chronic disease. Treatment...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Microsoft to Complete Nokia Purchase by April 25
Apr 23, 2014  
The Microsoft-Nokia deal that made headlines when it was announced is finally on its way to being completed. This proves that even the most complex deals do culminate with time. This week, Microsoft announced that it would complete the purchase of a major part of Nokia’s hardware assets by Friday. The much discussed deal-though on the brink of completion-has witnessed some adjustments...
Top End Stereo Systems Maker Harman Targets Chinese Auto Market
Apr 22, 2014  
Harman, the U.S.-based audio company that is best known as the provider of automobile stereos for top-end car models such as Mercedes-Benz, BMW and Ferrari, has said that it has signed agreements with two leading Chinese automakers—Chang’An and Geely. The company, that is associated with premium infotainment systems for leading auto makers, said that these new contracts...
Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...